compounding glp-1 enforcement news The FDA's Crackdown Continues: What to Know Drugmakers battle pharmacies over compounded

Our medical team will design a tailored protocol to support recovery, metabolic health, and sustainable growth hormone optimization through safe, science-backed care.

The New Nomad PRO now comes with a built-in temperature display

Added comments from neurologists and researchers about the trials findings.

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

regulate appetite, increase fullness, and support metabolism